229 related articles for article (PubMed ID: 15557288)
1. Heterogeneity of the neuropeptide Y (NPY) contractile and relaxing receptors in horse penile small arteries.
Prieto D; Arcos LR; Martínez P; Benedito S; García-Sacristán A; Hernández M
Br J Pharmacol; 2004 Dec; 143(8):976-86. PubMed ID: 15557288
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats.
Gradin KA; Buus CL; Li JY; Frøbert O; Simonsen U
Br J Pharmacol; 2006 Jul; 148(5):703-13. PubMed ID: 16715120
[TBL] [Abstract][Full Text] [Related]
3. Blunted pancreatic polypeptide-induced vasodilatation in mesenteric resistance vessels from spontaneously hypertensive rats.
Gradin KA; Li JY; Zhu H; Simonsen U
Eur J Pharmacol; 2008 Dec; 601(1-3):118-23. PubMed ID: 18851959
[TBL] [Abstract][Full Text] [Related]
4. Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues.
Hyland NP; Sjöberg F; Tough IR; Herzog H; Cox HM
Br J Pharmacol; 2003 Jun; 139(4):863-71. PubMed ID: 12813010
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y regulates intracellular calcium through different signalling pathways linked to a Y(1)-receptor in rat mesenteric small arteries.
Prieto D; Buus CL; Mulvany MJ; Nilsson H
Br J Pharmacol; 2000 Apr; 129(8):1689-99. PubMed ID: 10780975
[TBL] [Abstract][Full Text] [Related]
6. Contribution of K+ channels and ouabain-sensitive mechanisms to the endothelium-dependent relaxations of horse penile small arteries.
Prieto D; Simonsen U; Hernández M; García-Sacristán A
Br J Pharmacol; 1998 Apr; 123(8):1609-20. PubMed ID: 9605568
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
Haynes JM; Hill SJ; Selbie LA
Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
Fabi F; Argiolas L; Ruvolo G; del Basso P
Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349
[TBL] [Abstract][Full Text] [Related]
9. Functional antagonism between endogenous neuropeptide Y and calcitonin gene-related peptide in mesenteric resistance arteries.
De Mey JG; Megens R; Fazzi GE
J Pharmacol Exp Ther; 2008 Mar; 324(3):930-7. PubMed ID: 18055875
[TBL] [Abstract][Full Text] [Related]
10. Vasodilation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y1 receptors and is nitric oxide dependent.
Nilsson T; Lind H; Brunkvall J; Edvinsson L
Can J Physiol Pharmacol; 2000 Mar; 78(3):251-5. PubMed ID: 10721817
[TBL] [Abstract][Full Text] [Related]
11. Physiological regulation of penile arteries and veins.
Prieto D
Int J Impot Res; 2008; 20(1):17-29. PubMed ID: 17637789
[TBL] [Abstract][Full Text] [Related]
12. Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries.
Prieto D; Simonsen U; Nyborg NC
Br J Pharmacol; 1995 Nov; 116(6):2729-37. PubMed ID: 8590997
[TBL] [Abstract][Full Text] [Related]
13. Cotransmission from sympathetic vasoconstrictor neurons: differences in guinea-pig mesenteric artery and vein.
Smyth L; Bobalova J; Ward SM; Keef KD; Mutafova-Yambolieva VN
Auton Neurosci; 2000 Dec; 86(1-2):18-29. PubMed ID: 11269921
[TBL] [Abstract][Full Text] [Related]
14. Characterization of neuropeptide Y receptors mediating contraction, potentiation and inhibition of relaxation.
Nilsson T; You J; Sun X; Hedner T; Edvinsson L
Blood Press; 1996 May; 5(3):164-9. PubMed ID: 8790927
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y, Y1, Y2 and Y4 receptors mediate Y agonist responses in isolated human colon mucosa.
Cox HM; Tough IR
Br J Pharmacol; 2002 Mar; 135(6):1505-12. PubMed ID: 11906964
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
Malmström RE
Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
[TBL] [Abstract][Full Text] [Related]
17. Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats.
Gradin KA; Li JY; Andersson O; Simonsen U
J Vasc Res; 2003; 40(3):252-65. PubMed ID: 12902638
[TBL] [Abstract][Full Text] [Related]
18. Modulation of contractile function through neuropeptide Y receptors during development of cardiomyocyte hypertrophy.
Allen AR; Kelso EJ; Bell D; Zhao Y; Dickson P; McDermott BJ
J Pharmacol Exp Ther; 2006 Dec; 319(3):1286-96. PubMed ID: 16973886
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
Doods HN; Wienen W; Entzeroth M; Rudolf K; Eberlein W; Engel W; Wieland HA
J Pharmacol Exp Ther; 1995 Oct; 275(1):136-42. PubMed ID: 7562541
[TBL] [Abstract][Full Text] [Related]
20. Endothelium-independent potentiation by neuropeptide Y of vasoconstrictor responses in isolated arteries from rat and rabbit.
Gustafsson H; Nilsson H
Acta Physiol Scand; 1990 Apr; 138(4):503-7. PubMed ID: 2353579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
